You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Long-term Changes in Serum IGF-1 Levels After Successful Surgical Treatment of Growth HormoneSecreting Pituitary Adenoma

Shin, Mi-Seon MD*; Yu, Ji Hee MD*; Choi, Jong Han MD*; Jung, Chang Hee MD*; Hwang, Jenie Yoonoo MD*; Cho, Young Hyun MD; Kim, Chang Jin MD; Kim, Min-Seon MD, PhD*

Neurosurgery:
doi: 10.1227/01.neu.0000431480.87160.84
Research-Human-Clinical Studies
Abstract

BACKGROUND: Successful treatment of acromegaly is known to normalize serum insulin-like growth factor 1 (IGF-1) levels within days after surgery. However, our clinical observations indicate that many cases of acromegaly show delayed normalization of serum IGF-1 levels after complete tumor resection.

OBJECTIVE: To study long-term changes of the serum IGF-1 levels in acromegalic patients for whom surgical treatment was thought to be successful.

METHODS: A retrospective observational study was performed with 46 acromegalic patients with no residual tumor on sellar magnetic resonance imaging, and a nadir growth hormone of less than 0.4 μg/L on a postoperative oral glucose tolerance test.

RESULTS: In all patients, serum IGF-1 levels returned to the normal reference values for age and sex during the observational period (12-132 months). The mean duration from the time of surgery until IGF-1 normalization was 10 months (range, 3 days-57 months). Twenty-seven patients (59%) reached normal IGF-1 ranges within 3 months of surgery, whereas 19 patients (41%) experienced delayed (>3 months) IGF-1 normalization. Eleven patients (24%) recovered normal IGF-1 levels 12 to 57 months after surgery. The possibility of delayed IGF-1 cure was increased 8.8-fold with an immediate postoperative IGF-1 level increase of 100 μg/L.

CONCLUSION: Satisfactory remission of acromegaly by IGF-1 criteria was delayed in a large proportion of acromegalic patients, especially those with high postoperative IGF-1 levels. Hence, additional treatment can be delayed in clinically stable acromegalic patients who show no evidence of residual tumors on postoperative magnetic resonance imaging and a normal growth hormone suppressive response to a glucose load.

ABBREVIATIONS: GH, growth hormone

IGF-1, insulin-like growth factor 1

OGTT, oral glucose tolerance test

SDS, SD score

TSA, transsphenoidal adenectomy

Author Information

*Division of Endocrinology and Metabolism, Department of Internal Medicine;

Department of Neurosurgery, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

Correspondence: Min-Seon Kim, MD, PhD, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea. E-mail: mskim@amc.seoul.kr

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.neurosurgery-online.com).

Received January 13, 2013

Accepted May 20, 2013

Copyright © by the Congress of Neurological Surgeons